Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 4/20 | 0.43 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | ATP4A | P20648 | 4/20 | 0.40 |
| ▸ | ATP4B | P51164 | 4/20 | 0.40 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | DHFR | P00374 | 2/20 | 0.38 |
| ▸ | DRD2 | P14416 | 3/20 | 0.36 |
| ▸ | DRD3 | P35462 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5137888 | 0.95 | CRHR1 (0.41) | CRHR1C5AR1PPARGPPARAATP4A | |
| SCHEMBL5138032 | 0.94 | C5AR1 (0.43) | CRHR1C5AR1PPARGPPARAATP4A | |
| SCHEMBL5136840 | 0.92 | C5AR1 (0.41) | CRHR1C5AR1PPARGPPARATRPM8 | |
| SCHEMBL5137638 | 0.91 | C5AR1 (0.41) | CRHR1C5AR1PPARGPPARATRPM8 | |
| SCHEMBL5136018 | 0.91 | C5AR1 (0.41) | CRHR1C5AR1PPARGPPARAATP4A | |
| SCHEMBL5135861 | 0.90 | CRHR1 (0.44) | CRHR1C5AR1PPARGPPARAATP4A | |
| SCHEMBL651505 | 0.89 | C5AR1 (0.40) | CRHR1C5AR1PPARGPPARAATP4A | |
| SCHEMBL5136025 | 0.89 | TRPM8 (0.45) | TRPM8 | |
| SCHEMBL5135363 | 0.89 | C5AR1 (0.44) | CRHR1C5AR1ATP4AATP4BTSHR | |
| SCHEMBL5134960 | 0.89 | ATP4A (0.52) | PPARGPPARAATP4AATP4BDRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490044-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORP (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1490044-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003084524-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |